Withdrawal phenomena and dependence syndrome after the consumption of "spice gold".

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Deutsches Ärzteblatt International

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3238/arztebl.2009.0464PMID 19652769PMCID PMC2719097
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?

  2009cited by this paper
• Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes.

  2005cited by this paper
• Strong increase in total delta‐THC in cannabis preparations sold in Dutch coffee shops

  2005cited by this paper
• Review of the validity and significance of cannabis withdrawal syndrome.

  2004cited by this paper
• Bongs, a Method of Using Cannabis Linked to Dependence

  2003cited by this paper
• Abhängigkeit von „Non- Benzodiazepinhypnotika”Zwei Fallberichte

  1999cited by this paper
• [Dependency of non-benzodiazepine hypnotics. Two case reports].

  1999cited by this paper

• Acute and long-term psychiatric consequences of synthetic cannabinoids and related novel psychoactive substances: A systematic review.

  2026cites this paper
• Synthetische Cannabinoide: eine narrative Übersicht

  2025cites this paper
• Assessment of Abuse Potential of Three Indazole-Carboxamide Synthetic Cannabinoids 5F-ADB, MDMB-4en-PINACA and ADB-4en-PINACA

  2025cites this paper
• Toxicological Impact of Synthetic Cannabinoid JWH-200 on Hematological and Oxidative Biomarkers in Rats

  2025cites this paper
• The utility of a new point-of-care test for synthetic cannabinoids: a mixed-methods study in people who use synthetic cannabinoids and stakeholders

  2025cites this paper
• Synthetic Cannabinoid Withdrawal: A Systematic Review of Case Reports

  2025cites this paper
• Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer's Disease.

  2023cites this paper
• The Old and the New: Cardiovascular and Respiratory Alterations Induced by Acute JWH-018 Administration Compared to Δ9-THC—A Preclinical Study in Mice

  2023cites this paper
• Sex‐specific behavioural, metabolic, and immunohistochemical changes after repeated administration of the synthetic cannabinoid AKB48 in mice

  2023cites this paper
• Narrative Review of the Pharmacodynamics, Pharmacokinetics, and Toxicities of Illicit Synthetic Cannabinoid Receptor Agonists.

  2023cites this paper
• Cognitive dysfunction and impaired neuroplasticity following repeated exposure to the synthetic cannabinoid JWH‐018 in male mice

  2023cites this paper
• Characterization of the pyrolysis patterns of 44 synthetic cannabinoids and their application in illicit drug analysis

  2023cites this paper
• Synthetic cannabinoids (SC)

  2022cites this paper
• Detection of the Synthetic Cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in Biological Matrices: A Systematic Review

  2022cites this paper
• Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.

  2022cites this paper
• Addiction and treatment of novel psychoactive substance dependence

  2022cites this paper
• Synaptic changes induced by cannabinoid drugs and cannabis use disorder

  2022cites this paper
• Emergence of Synthetic Cannabinoids as Drugs of Abuse

  2022cites this paper
• Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors.

  2022cites this paper
• Synthetic cannabinoids in Europe – a review

  2021cites this paper
• Determination of in vitro human whole blood-to-plasma ratio of THJ-018 utilizing gas chromatography–Mass spectrometry

  2021cites this paper
• Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings

  2021cites this paper
• Analytical findings in a non-fatal intoxication with the synthetic cannabinoid 5F-ADB (5F-MDMB-PINACA): a case report

  2021cites this paper
• Cathinone und synthetische Cannabinoide

  2021cites this paper
• Comparison of Water Pipes vs Other Modes of Cannabis Consumption and Subsequent Illicit Drug Use in a Longitudinal Cohort of Young Swiss Men

  2021cites this paper
• Abuse Potential of Synthetic Cannabinoids: AM-1248, CB-13, and PB-22

  2021cites this paper
• In vitro assessment of the cytotoxic, genotoxic and oxidative stress effects of the synthetic cannabinoid JWH-018 in human SH-SY5Y neuronal cells.

  2020cites this paper
• Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions


  2020cites this paper
• Toxicologie des Cathinones « Sels de bain »

  2020cites this paper
• Historical and Current Perspectives of Synthetic Marijuana: Critical Review.

  2020cites this paper
• THE SUB CHRONIC TOXIC EFFECT OF VOODOO EXTRACT ON THE CENTRAL NERVOUS SYSTEM IN ADULT MALE ALBINO RATS

  2020cites this paper
• Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids.

  2020cites this paper
• Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a ynthetic cannabinoid (SCB)

  2020cites this paper
• The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review

  2020cites this paper
• Designers Drugs—A New Challenge to Emergency Departments—An Observational Study in Poland

  2020cites this paper
• New and Emerging Illicit Psychoactive Substances

  2020cites this paper
• Nausea-Induced Conditioned Gaping Reactions in Rats Produced by High-Dose Synthetic Cannabinoid, JWH-018

  2020cites this paper
• The use of synthetic cannabinoid receptor agonists (SCRAs) within the homeless population: motivations, harms and the implications for developing an appropriate response

  2020influential citation
• Impact of At Least 2 Years of Synthetic Cannabinoid Use on Cognitive and Psychomotor Functions Among Treatment-Seeking Male Outpatients

  2020cites this paper
• technical report on the new psychoactive substance methyl 2-{ [ 1-( 4-fluorobutyl )-1 H-indole-3-carbonyl ] amino }-3 , 3-dimethylbutanoate ( 4 F-MDMB-BICA )

  2020cites this paper
• Critical Illness Secondary to Synthetic Cannabinoid Ingestion

  2020cites this paper
• [Optimization of treatment of acute poisoning with severe psychodisleptics].

  2020cites this paper
• Designer drugs: mechanism of action and adverse effects

  2020cites this paper
• Functional effects of synthetic cannabinoids versus Δ9‐THC in mice on body temperature, nociceptive threshold, anxiety, cognition, locomotor/exploratory parameters and depression

  2019cites this paper
• Determination of synthetic and natural cannabinoids in oral fluid by solid-phase microextraction coupled to gas chromatography/mass spectrometry: A pilot study.

  2019cites this paper
• The Drugs May Be Synthetic but the Consequences are not:Analysis of Synthetic Cannabinoid User Accounts

  2019cites this paper
• Drug treatment strategies for insomnia in patients with post-traumatic stress disorder

  2019cites this paper
• Synthetic cannabinoid use disorder: an update for general psychiatrists

  2019cites this paper
• Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders

  2019cites this paper
• JWH-018

  2019cites this paper
• Spice

  2019cites this paper
• Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice.

  2019cites this paper
• Medical Causes of Psychosis: Lessons for Individuals with Attenuated Psychosis Syndromes

  2019cites this paper
• Evidence for public health on novel psychoactive substance use: a mixed-methods study

  2019cites this paper
• Investigation of the Clinical Course and Outcomes of Bonsai Use

  2019cites this paper
• Synthetic cannabinoid use among college students.

  2019cites this paper
• Cannabinoid Withdrawal Produces Altered Somatic and Emotionality-related Behavior in Mice

  2019cites this paper
• The severity of dissociative symptoms among patients with cannabis and synthetic cannabinoid use disorder: association with substance use characteristics and suicide

  2018influential citation
• Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH‐018: a phase 1, placebo‐controlled, pilot study

  2018influential citation
• Mood Fluctuation and Psychobiological Instability: The Same Core Functions Are Disrupted by Novel Psychoactive Substances and Established Recreational Drugs

  2018cites this paper
• Evaluation of cognitive functions in individuals with synthetic cannabinoid use disorder and comparison to individuals with cannabis use disorder.

  2018cites this paper
• Report on the risk assessment of N-(1- amino-3-methyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3- carboxamide in the framework of the Council Decision on new psychoactive substances

  2018cites this paper
• Synthetic cannabinoid AM2201 induces seizures: Involvement of cannabinoid CB1 receptors and glutamatergic transmission

  2018cites this paper
• Acil serviste Bonsai intoksikasyonu yönetimi: 61 olgunun incelenmesi

  2018cites this paper
• Synthetic Cannabinoid Use

  2018cites this paper
• Perceived Risk of Emerging Recreational Drugs: Impact of Anecdotal and Statistical Evidence

  2018cites this paper
• Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.

  2018cites this paper
• New psychoactive substances: new service provider challenges

  2018cites this paper
• Conditioned gaping produced by high dose &Dgr;9‐tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system

  2018cites this paper
• Synthetic Cannabinoids and Synthetic Cannabinoid-Induced Psychotic Disorders

  2018cites this paper
• The Consumption of New Psychoactive Substances and Methamphetamine.

  2018cites this paper
• New and Emerging Illicit Psychoactive Substances.

  2018cites this paper
• The effects of synthetic cannabinoids (SCs) on brain structure and function.

  2018cites this paper
• Profiling of Impurities in Samples of Synthetic Cannabinoids Seized from Illegal Circulation in the Siberian Region of the Russian Federation

  2018cites this paper
• Synthetic Cannabinoids (SCs) in Metaphors: a Metaphorical Analysis of User Experiences of Synthetic Cannabinoids in Two Countries

  2018influential citation
• The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review

  2018cites this paper
• Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis

  2017cites this paper
• Exploring the risks, harms and pleasures of licit and illicit substance use:a study of young people in a South-Yorkshire town

  2017cites this paper
• DESIGNER DRUGS: A BRIEF HISTORY OF THE ATTEMPT TO SYSTEMIZE ON THE EXAMPLES OF “SPICE” AND “SALTS”

  2017cites this paper
• Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013–2015

  2017cites this paper
• A Profile of Synthetic Cannabinoid Users

  2017cites this paper
• Synthetic Cannabinoid Receptor Agonists (Spice) as New Recreational Psychoactive Substances

  2017cites this paper
• [Synthetic cannabinoids: A new addiction matrix].

  2017cites this paper
• A new challenge in forensic toxicology exemplified by a case of murder under the influence of a synthetic cannabinoid - AM-2201.

  2017cites this paper
• Impact of synthetic cannabinoids on the duration of opioid‐related withdrawal and craving among patients of addiction clinics in Kazakhstan: A prospective case–control study

  2017cites this paper
• Synthetic Pot: Not Your Grandfather's Marijuana.

  2017cites this paper
• The effects of synthetic cannabinoids on executive function

  2017cites this paper
• Synthetic Cathinones and Cannabinoids are New Psychoactive Substances (Review)

  2017cites this paper
• Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.

  2017cites this paper
• Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature.

  2017cites this paper
• Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.

  2017cites this paper
• User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes

  2017cites this paper
• Acute effects of synthetic cannabinoids: Update 2015

  2017cites this paper
• The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations.

  2017cites this paper
• New Psychoactive Substances (NPS) – a Challenge for the Addiction Treatment Services

  2017cites this paper
• Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset.

  2017cites this paper
• Recreational stimulants, herbal, and spice cannabis: The core psychobiological processes that underlie their damaging effects

  2017cites this paper
• Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.

  2017cites this paper
• An approach to the new psychoactive drugs phenomenon

  2017cites this paper
• Novel psychoactive substances: types, mechanisms of action, and effects

  2017cites this paper